Nabil F. Saba - Esophageal Cancer: Prevention, Diagnosis and Therapy

This Springer imprint is published by the registered company Springer Nature Switzerland AG

The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland

Esophageal cancer is a major cause of cancer-related mortality worldwide. In the Western world, there has been a change in esophageal cancer presentation due to the rapidly rising incidence of distal esophageal adenocarcinoma. The heterogeneity of the disease and its aggressive clinical course has rendered the task of the development of an optimal multimodal management approach a challenging one. On the brighter side, there has been a noted surge in exploring novel therapeutic approaches in medical, surgical, and radiation therapy, including immune-based and targeted approaches, as well as palliative and nutritional supportive care.

Esophageal Cancer: Prevention, Diagnosis and Therapy,second edition, provides a unique and updated comprehensive review of the current epidemiology, molecular biology, staging, and treatment of cervical, thoracic, and junctional tumors. In addition, it highlights the differences in etiology, prognosis, and management of squamous cell and adenocarcinomas of the esophagus.

Promising novel diagnostic approaches and an in-depth review of cellular and molecular biology of premalignant lesions, the role of immunotherapy, as well as palliative and nutritional aspects are discussed in depth. We hope this second edition will further incite the interest of specialists from various diagnostic and therapeutic disciplines and will promote further research in the field of esophageal cancer.

The editors acknowledge

Anthea Hammond for editorial contribution

Nefertiti Hawthorne for communication